Biography

A leading expert on the legal, ethical, and social issues surrounding health law and the biosciences, Hank Greely (BA ’74) specializes in the implications of new biomedical technologies, especially those related to neuroscience, genetics, and stem cell research. He frequently serves as an advisor on California, national, and international policy issues. He is chair of California’s Human Stem Cell Research Advisory Committee and a co-director of the Law and Neuroscience Project, funded by the MacArthur Foundation. Active in university leadership, Professor Greely chairs the steering committee for the Stanford Center for Biomedical Ethics and directs both the law school’s Center for Law and the Biosciences and the Stanford Center for Biomedical Ethics’ Program in Neuroethics. Professor Greely serves on the Scientific Leadership Council for the university’s interdisciplinary Bio-X Program.

Before joining the Stanford Law School faculty in 1985, Greely was a partner at Tuttle & Taylor, served as a staff assistant to the secretary of the U.S. Department of Energy, and as special assistant to the general counsel of the U.S. Department of Defense. He served as a law clerk to Justice Potter Stewart of the U.S. Supreme Court and to Judge John Minor Wisdom of the Court of Appeals for the Fifth Circuit.

Greely is also a professor (by courtesy) of genetics at Stanford School of Medicine.

Key Works

• Henry T. Greely, The Uneasy Ethical and Legal Underpinnings of Large-Scale Genomic Biobanks 8 Annual Review of Genomics and Human Genetics 343 (September 2007).
• Henry T. Greely and Judy Illes, Neuroscience-Based Lie Detection: The Urgent Need for Regulation, 33 American Journal of Law & Medicine 377 (2007).
• Henry T. Greely, Mildred K. Cho, Linda F. Hogle, Debra M. Satz, Thinking About the Human Neuron Mouse, 7 American Journal of Bioethics: Neuroethics 25 (2007).
• Henry T. Greely, The Social Consequences of Advances in Neuroscience: Legal Problems; Legal Perspectives in Neuroethics: Defining the Issues In Theory, Practice and Policy, Judy Illes, ed., Oxford, England: Oxford University Press, 2005.
• Henry T. Greely, Genotype Discrimination: The Complex Case for Some Legislative Protection, 149 University of Pennsylvania Law Review 1483-1505 (2001).

In the News

• Professors View Prolonging Life As Cruel, If Death Is Inevitable
  Monterey County Herald, November 10, 2009
• Brave Thinkers
  The Atlantic, November 01, 2009
• We Are Neuroscientists And We Come In Peace
  Science - Findings, October 18, 2009
• True Lies
  ABA Journal, October 01, 2009
• Pill Power
  Discover Presents The Brain, September 28, 2009

Courses & Programs

Courses

• Contracts
• FDA's Regulation of Health Care
• Health Law & Policy I
• Health Law & Policy II
• Law and Biosciences
• Law and the Biosciences: Genetics

Programs

• Center for Law and the Biosciences, Director
• Stanford Program in Law, Science & Technology, Deane F. and Kate Edelman Johnson Professor of Law

Publications & Cases

Recent Publications View All

• Henry T. Greely, Law and the Revolution in Neuroscience: An Early Look at the Field, 42 Akron Law Review 687 (2009).
• Henry T. Greely, Neuroscience-Based Lie Detection: The Need for Regulation, in Using Imaging to Identify Deceit: Scientific and Ethical Questions, Emilio Bizzi, et. al., Cambridge, MA: American Academy of ARts and Sciences, May 2009.
• P. Duggan, A.W. Siegel, D.M. Blass, H.T. Greely, et. al., Unintended Changes in Cognition, Mood, and Behavior Arising from Cell-Based Interventions for Neurological Conditions: Ethical Challenges, 9 Neuroscience 31 (May 2009).
• Henry T. Greely, Who Knows What Evil Lurks in the Hearts of Men?: Behavioral Genomics, Neuroscience, Criminal Law, and the Search for Hidden Knowledge, in The Impact of Behavioral Sciences on Criminal Law, Nita Farahany, ed., New York: Oxford University Press (March 2009).
• Henry Greely, Barbara Sahakian, John Harris, Ronald C. Kessler, Michael Gazzaniga, Philip Campbell, and Martha J. Farah, Towards Responsible Use of Cognitive-Enhancing Drugs by the Healthy, Nature, December 7, 2008.
• Mildred K. Cho, Sara L. Tobin, Henry T. Greely, Jennifer McCormick, Angie Boyce and David Magnus, Research Ethics Consultation: The Stanford Experience, 30 IRB: Ethics and Human Research 1 (November/December 2008).
• Henry T. Greely, Genetic Genealogy: Genetics Meets the Marketplace, in Revisiting Race in a Genomic Age, Barbara A. Koenig, Sandra Soo-Jin Lee and Sarah S. Richardson, New Brunswick, N.J.: Rutgers University Press, October 2008.
• Henry T. Greely, What the Heck is 'Law and Biosciences' - and Why Do We Need It? Stanford Center for Law and the Biosciences Blog, September 23, 2008.
• Sandra Soo-Jin Lee, Joanna Mountain, Barbara Koenig, Russ Altman, Melissa Brown, Albert Camarillo, Luca Cavalli-Sforza, Mildred Cho, Jennifer Eberhardt, Marcus Feldman, Richard Ford, Henry Greely, Roy King, Hazel Markus, Debra Satz, Matthew Snipp, Claude Steele and Peter Underhill, Open Letter - The Ethics of Characterizing Difference: Guiding Principles on using Racial Categories in Human Genetics, 9 Genome Biology art. 404 (July 2008).
• D.J.M. Mathews, Henry T. Greely, et.al., Cell-Based Interventions for Neurologic Conditions: Ethical Challenges for Early Human Trials, 71 Neurology 288 (July 2008).

Affiliations & Honors

Professional Affiliations

• Chair (1996-Present), Steering Committee, Stanford Center for Biomedical Ethics (SCBE)
• Chair (2002-2003), Stanford Faculty Senate
• Chair, Working Group on Stem Cell Research Policy Implementation
• Co-chair, Stanford Program in Organizing Neuroethics Education and Research
• Director, Stanford Program on Stem Cells in Society, SCBE
• Ethics Chair, North American Committee, Human Genome Diversity Project
• Ethics Officer, World Cell Line Collection 1 (Collaboration between the Human Genome Diversity Project and the Centre de l'Etude de Polymorphism Humain

• Member, Center for Integrating Research in Genetics and Ethics, SCBE
• Member, Stanford Program on Neuroethics, SCBE
• Member, Working Group on Human Trials of Cell Based Interventions for Neurological Conditons, John Hopkins University
• Member (2002-Present), Faculty Leadership Council, Bio-X Program
• Member, Scientific Advisory Committee and Ethics Advisory Committees, Deparment of Veterans' Affairs, DNA Bank Project
• Member, Genetics Advisory Board, Deparment of Veterans' Affairs, BEST Study
• Member, Ethics Committee, American Society for Gene Therapy
• Member, Ethics Committee, International Society for Stem Cell Research
• Member, Scientific Advisory Committee, Stem Cell Network (Canada)
• Member, Ethics Advisory Board, Affymetrix, Inc.
• Member, Executive Committee, France Stanford Center for Interdisciplinary Studies
• Member, Steering Committee, Neuroscience Institute at Stanford
• Member, Advisory Committee, Stanford Institute for Clinical Information
• Member, Advisory Committee, Stanford Comprehensive Cancer Center
• Member, Executive Committee, Stanford Program in Regenerative Medicine
• Member, Operations Subcommittee
• Member, Bioethics Subcommittee